Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Familial chylomicronemia syndrome: importance of diagnostic vigilance. | Transl Pediatr | 2022 | 36345451 | PubTator, text mining | PubMed |
| Novel pathogenic variant combination in LPL causing familial chylomicronemia syndrome in an Asian family and experimental validation in vitro: a case report. | Transl Pediatr | 2022 | 36345447 | PubTator, text mining | PubMed |
| Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. | Front Cardiovasc Med | 2022 | 36324753 | PubTator, text mining | PubMed |
| Chylomicronemia through a burr hole: A case report. | Front Cardiovasc Med | 2022 | 36312279 | PubTator, text mining | PubMed |
| Quantitative comparison of the protein corona of nanoparticles with different matrices. | Int J Pharm X | 2022 | 36304137 | PubTator, text mining | PubMed |
| Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. | Pharmaceuticals (Basel) | 2022 | 36297390 | PubTator, text mining | PubMed |
| Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome. | Metabolites | 2022 | 36295861 | PubTator, text mining | PubMed |
| Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST Study. | Int J Mol Sci | 2022 | 36293255 | PubTator, text mining | PubMed |
| Integrated Quantitative Targeted Lipidomics and Proteomics Reveal Unique Fingerprints of Multiple Metabolic Conditions. | Biomolecules | 2022 | 36291648 | PubTator, text mining | PubMed |
| Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights. | Front Cardiovasc Med | 2022 | 36267630 | PubTator, text mining | PubMed |
| Placental proteome in late‑onset of fetal growth restriction. | Mol Med Rep | 2022 | 36263610 | PubTator, text mining | PubMed |
| Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers. | Int J Mol Sci | 2022 | 36232415 | PubTator, text mining | PubMed |
| Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. | J Am Heart Assoc | 2022 | 36216435 | PubTator, text mining | PubMed |
| Safety and Efficacy of Insulin and Heparin in the Management of Hypertriglyceridemia-Induced Pancreatitis in a Patient without Diabetes: A Case Report. | Case Rep Endocrinol | 2022 | 36203643 | PubTator, text mining | PubMed |
| Renal amyloidosis: a new time for a complete diagnosis. | Braz J Med Biol Res | 2022 | 36197414 | PubTator, text mining | PubMed |
| Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy. | J Clin Lipidol | 2022 | 36195542 | PubTator, text mining | PubMed |
| Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients. | Front Immunol | 2022 | 36189295 | PubTator, text mining | PubMed |
| Emerging prediction methods for early diagnosis of necrotizing enterocolitis. | Front Med (Lausanne) | 2022 | 36186788 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia. | Intern Med | 2022 | 36184534 | PubTator, text mining | PubMed |
| Familial chylomicronemia syndrome: The first case reported in Ecuador. | Clin Investig Arterioscler | 2022 | 36184299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=21